Midazolam use in the emergency department

Area of Science:

• Emergency Medicine
• Pharmacology

Background:

• Midazolam is a water-soluble benzodiazepine with amnestic, sedative, hypnotic, anxiolytic, and anticonvulsant properties.
• It is significantly more potent than diazepam and widely used in outpatient settings.
• Safety data for midazolam in emergency department (ED) patients was previously undocumented.

Purpose of the Study:

• To evaluate the safety and efficacy of intravenous midazolam use in an emergency department setting.
• To determine the complication rate associated with midazolam administration in ED patients.

Main Methods:

• Retrospective review of 389 patients who received intravenous midazolam over a 2-year period.
• Data collected included patient demographics, dosage, co-administered medications, and adverse events.
• Analysis focused on complication rates, specifically respiratory depression and hypotension.

Main Results:

• The overall complication rate was low at 1.0%.
• Two patients (0.5%) experienced significant respiratory depression, both of whom also received fentanyl citrate and were successfully treated with naloxone.
• Two patients (0.5%) had transient hypotension, with no long-term sequelae observed.

Conclusions:

• Midazolam can be safely used in the emergency department for procedural sedation and agitation control.
• Close patient monitoring, careful dosing, and titration are crucial for maximizing safety.
• The study supports the judicious use of midazolam in ED settings when appropriate precautions are taken.